{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T14:10:54Z","timestamp":1795183854458,"version":"4.10.3"},"reference-count":57,"publisher":"FapUNIFESP (SciELO)","issue":"suppl 19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:p>SUMMARYAIDS-related cryptococcal meningitis continues to cause a substantial burden of death in low and middle income countries. The diagnostic use for detection of cryptococcal capsular polysaccharide antigen (CrAg) in serum and cerebrospinal fluid by latex agglutination test (CrAg-latex) or enzyme-linked immunoassay (EIA) has been available for over decades. Better diagnostics in asymptomatic and symptomatic phases of cryptococcosis are key components to reduce mortality. Recently, the cryptococcal antigen lateral flow assay (CrAg LFA) was included in the armamentarium for diagnosis. Unlike the other tests, the CrAg LFA is a dipstick immunochromatographic assay, in a format similar to the home pregnancy test, and requires little or no lab infrastructure. This test meets all of the World Health Organization ASSURED criteria (Affordable, Sensitive, Specific, User friendly, Rapid\/robust, Equipment-free, and Delivered). CrAg LFA in serum, plasma, whole blood, or cerebrospinal fluid is useful for the diagnosis of disease caused by Cryptococcusspecies. The CrAg LFA has better analytical sensitivity for C. gattii than CrAg-latex or EIA. Prevention of cryptococcal disease is new application of CrAg LFA via screening of blood for subclinical infection in asymptomatic HIV-infected persons with CD4 counts &lt; 100 cells\/mL who are not receiving effective antiretroviral therapy. CrAg screening of leftover plasma specimens after CD4 testing can identify persons with asymptomatic infection who urgently require pre-emptive fluconazole, who will otherwise progress to symptomatic infection and\/or die.<\/jats:p>","DOI":"10.1590\/s0036-46652015000700008","type":"journal-article","created":{"date-parts":[[2015,10,11]],"date-time":"2015-10-11T01:17:29Z","timestamp":1444526249000},"page":"38-45","source":"Crossref","is-referenced-by-count":96,"title":["LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY"],"prefix":"10.1590","volume":"57","author":[{"given":"Jose E.","family":"VIDAL","sequence":"first","affiliation":[{"name":"Instituto de Infectologia Em\u00edlio Ribas,  Brasil; Universidade de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"BOULWARE","sequence":"additional","affiliation":[{"name":"University of Minnesota,  USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","first-page":"6","article-title":"AIDS-associated cryptoccocosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras","volume":"10","author":"Antinori S","year":"2008","journal-title":"Experience of a single centre in Italy. HIV Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"471363","DOI":"10.1155\/2013\/471363","article-title":"New insights into HIV\/AIDS-associated cryptococcosis","volume":"2013","author":"Antinori S","year":"2013","journal-title":"ISRN AIDS"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral na\u00efve or antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"Bicanic T","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/604716","article-title":"Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients","volume":"49","author":"Bicanic T","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1128\/CVI.00446-12","article-title":"Comparison of four assays for the detection of cryptococcal antigen","volume":"19","author":"Binnicker MJ","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3201\/eid2001.130906","article-title":"Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast","volume":"20","author":"Boulware DR","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001950","article-title":"Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era","volume":"3","author":"Charlier C","year":"2008","journal-title":"PLOS ONE"},{"key":"ref8","first-page":"981","article-title":"Cryptococcus gattiiinfections","volume":"27","author":"Chen SC","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.10827","article-title":"Changing incidence of central nervous system diseases in the EuroSIDA cohort","volume":"55","author":"d'Arminio Monforte A","year":"2004","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/01.aids.0000163944.39306.7c","article-title":"The decline of incident cases of HIV-associated neurological disorders in San Francisco, 1991-2003","volume":"19","author":"Dilley JW","year":"2005","journal-title":"AIDS"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00002030-200402200-00024","article-title":"Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras","volume":"18","author":"Dromer F","year":"2004","journal-title":"AIDS"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1371\/journal.pmed.0040021","article-title":"Determinants of disease presentation and outcome during cryptococcosis: the Crypto A\/D Study","volume":"4","author":"Dromer F","year":"2007","journal-title":"PLOS Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7196\/sajhivmed.930","article-title":"Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update","volume":"14","author":"Govender NP","year":"2013","journal-title":"S Afr HIV Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/hiv.12245","article-title":"Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa","volume":"16","author":"Govender NP","year":"2015","journal-title":"HIV Med"},{"issue":"Suppl 4","key":"ref15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/01.aids.0000279705.24428.a3","article-title":"Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives","volume":"21","author":"Greco DB","year":"2007","journal-title":"AIDS"},{"issue":"Suppl 1","key":"ref16","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1590\/S0102-311X2000000700003","article-title":"Estudo temporal das doen\u00e7as associadas \u00e0 AIDS no Brasil, 1980-1999","volume":"16","author":"Guimar\u00e3es MD","year":"2000","journal-title":"Cad Saude Publica"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/QAD.0b013e328322ffc3","article-title":"The burden of HIV-associated cryptococcal disease","volume":"23","author":"Harrison TS","year":"2009","journal-title":"AIDS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1097\/QAD.0b013e3282a4a64d","article-title":"HIV-associated cryptococcal meningitis","volume":"21","author":"Jarvis JN","year":"2007","journal-title":"AIDS"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/QAD.0b013e32832be0fc","article-title":"High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out","volume":"23","author":"Jarvis JN","year":"2009","journal-title":"AIDS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2334-10-67","article-title":"Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases","volume":"10","author":"Jarvis JN","year":"2010","journal-title":"BMC Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/cid\/cir613","article-title":"Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis","volume":"53","author":"Jarvis JN","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/1545109712459077","article-title":"Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation","volume":"11","author":"Jarvis JN","year":"2012","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes","volume":"58","author":"Jarvis JN","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/cid\/cit641","article-title":"Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid","volume":"58","author":"Kabanda T","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/587667","article-title":"Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy","volume":"46","author":"Kambugu A","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"ref26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy","volume":"30","author":"Kaplan JE","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1517\/17530059.2012.681300","article-title":"CrAg Lateral Flow Assay for Cryptococcosis","volume":"6","author":"Kozel TR","year":"2012","journal-title":"Expert Opin Med Diagn"},{"key":"ref28","first-page":"1","article-title":"Official information systems for cryptococcal meningitis, state of Rio de Janeiro, Southeastern Brazil","volume":"43","author":"Leimann BCQ","year":"2009","journal-title":"Rev Sa\u00fade P\u00fablica"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1590\/S0036-46652008000200002","article-title":"Clinical and epidemiological features of 123 cases of cryptococcosis in Mato Grosso do Sul, Brazil","volume":"50","author":"Lindenberg A de S","year":"2008","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/cid\/cir379","article-title":"Evaluation of newly developed lateral flow immunoassay for the diagnosis of cryptococcosis","volume":"53","author":"Lindsley MD","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref31","series-title":"Cryptococcus: from human pathogen to model yeast","first-page":"97","volume-title":"Population structure and ecology ofCryptococcus neoformansandCryptococcus gattii","author":"Litvintseva AP","year":"2011"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/01.aids.0000252060.80704.68","article-title":"Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy","volume":"20","author":"Lortholary O","year":"2006","journal-title":"AIDS"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-0034-1372342","article-title":"New approaches to the diagnosis and treatment of cryptococcal meningitis","volume":"34","author":"Makadzange AT","year":"2014","journal-title":"Semin Neurol"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049541","article-title":"Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory","volume":"7","author":"McMullan BJ","year":"2012","journal-title":"PLOS ONE"},{"key":"ref35","first-page":"117","article-title":"Disseminated cryptococcosis in patients with AIDS","volume":"34","author":"Metta HA","year":"2002","journal-title":"Clinical, microbiological, and immunologoical analysis of 51 patients. Rev Argent Microbiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells\/microL who start HIV therapy in resource-limited settings","volume":"51","author":"Meya DB","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"9983","key":"ref37","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial","volume":"385","author":"Mfinanga S","year":"2015","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1086\/368091","article-title":"The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas","volume":"36","author":"Mirza SA","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref39","first-page":"218","article-title":"Cryptococcosis en pacientes con SIDA: estudio de casos en el Hospital Paroissien en el periodo 1996-2007","volume":"40","author":"M\u00f3naco LS","year":"2008","journal-title":"Rev Argent Microbiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11046-011-9504-9","article-title":"Clinical, epidemiological and outcome features of patients with cryptococcosis in Uberaba, Minas Gerais, Brazil","volume":"173","author":"Mora DJ","year":"2012","journal-title":"Mycopathologia"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1590\/S0037-86822006000300005","article-title":"Cryptococcose: estudo epidemiol\u00f3gico, laboratorial e das variedades do fungo em 96 pacientes","volume":"39","author":"Moreira T de A","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"issue":"3","key":"ref42","first-page":"pii:S3","article-title":"Diagnosis and management of cryptococcal relapse","volume":"Suppl 3","author":"Musubire AK","year":"2013","journal-title":"J AIDS Clin Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1590\/S0037-86822006000200002","article-title":"Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience","volume":"39","author":"Oliveira JF","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park BJ","year":"2009","journal-title":"AIDS"},{"key":"ref45","first-page":"143","article-title":"Cryptococcemia","volume":"21","author":"Pasqualotto AC","year":"2004","journal-title":"An analysis of 28 cases with emphasis on the clinical outcome and its etiologic agent. Rev Iberoam Micol"},{"key":"ref46","series-title":"CrAg LFA: the new gold standard for diagnosis and prevention of cryptococcal disease","author":"Pelfrey J","year":"2015"},{"key":"ref47","first-page":"S1087","article-title":"Cryptococcosis diagnosis and treatment: what do we know now","volume":"pii","author":"Perfect JR","year":"2014","journal-title":"Fungal Genet Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/clinids\/18.5.789","article-title":"Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis","volume":"18","author":"Powderly WG","year":"1994","journal-title":"Clin Infect Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/QAI.0b013e31824c837e","article-title":"Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care","volume":"59","author":"Rajasingham R","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4269\/ajtmh.14-0452","article-title":"Epidemiology of meningitis in an HIV-infected Ugandan cohort","volume":"92","author":"Rajasingham R","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa065711","article-title":"Corticosteroids for bacterial meningitis in adults in Sub-Saharan Africa","volume":"357","author":"Scarborough M","year":"2007","journal-title":"N Engl J Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/QAI.0b013e3181a44f0a","article-title":"Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean","volume":"51","author":"Tuboi SH","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1590\/S0036-46652008000400004","article-title":"AIDS related progressive multifocal leukoencephalopathy: a retrospective study in a referral center in S\u00e3o Paulo, Brazil","volume":"50","author":"Vidal JE","year":"2008","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.diagmicrobio.2012.01.014","article-title":"Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort","volume":"73","author":"Vidal JE","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bjid.2012.10.020","article-title":"Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America","volume":"17","author":"Vidal JE","year":"2013","journal-title":"Braz J Infect Dis"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/cid\/civ263","article-title":"Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study","volume":"61","author":"Williams D","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref57","series-title":"Rapid advice: diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children","first-page":"1","year":"2011"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v57s19\/0036-4665-rimtsp-57-s19-00038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T06:43:31Z","timestamp":1495521811000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652015000800038&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":57,"journal-issue":{"issue":"suppl 19","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0036-46652015000800038"],"URL":"https:\/\/doi.org\/10.1590\/s0036-46652015000700008","relation":{},"ISSN":["0036-4665"],"issn-type":[{"value":"0036-4665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}